Zepp Health Corporation (ZEPP)
NYSE: ZEPP · Real-Time Price · USD
2.730
+0.040 (1.49%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Zepp Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 182.6 | 2,495 | 4,143 | 6,250 | 6,433 | Upgrade
|
| Revenue Growth (YoY) | -92.68% | -39.77% | -33.72% | -2.85% | 10.69% | Upgrade
|
| Cost of Revenue | 112.37 | 1,838 | 3,340 | 4,944 | 5,101 | Upgrade
|
| Gross Profit | 70.23 | 657.78 | 803.12 | 1,306 | 1,333 | Upgrade
|
| Selling, General & Admin | 71.33 | 503.07 | 696.24 | 696.62 | 620.46 | Upgrade
|
| Research & Development | 46.16 | 361.81 | 517.12 | 515.08 | 538.01 | Upgrade
|
| Operating Expenses | 117.48 | 864.88 | 1,213 | 1,212 | 1,158 | Upgrade
|
| Operating Income | -47.25 | -207.1 | -410.24 | 93.94 | 174.2 | Upgrade
|
| Interest Expense | -5.55 | -47.7 | -57 | -44.88 | -22.62 | Upgrade
|
| Interest & Investment Income | 3.67 | 21.92 | 12.33 | 16.69 | 46.12 | Upgrade
|
| Earnings From Equity Investments | -4.21 | 8.38 | 17.66 | 41.03 | -4.75 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.66 | -3.66 | 43.82 | 27.42 | -0.93 | Upgrade
|
| EBT Excluding Unusual Items | -54 | -228.17 | -393.43 | 134.19 | 192.01 | Upgrade
|
| Gain (Loss) on Sale of Investments | -8.12 | -0.24 | 38.56 | 13.51 | 12.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 56.52 | Upgrade
|
| Pretax Income | -62.12 | -228.4 | -354.88 | 147.7 | 260.86 | Upgrade
|
| Income Tax Expense | 13.69 | -15.82 | -65.88 | 10.75 | 31.15 | Upgrade
|
| Earnings From Continuing Operations | -75.81 | -212.58 | -289 | 136.95 | 229.71 | Upgrade
|
| Minority Interest in Earnings | 0.08 | 0.47 | 0.69 | 0.85 | -0.95 | Upgrade
|
| Net Income | -75.73 | -212.12 | -288.31 | 137.8 | 228.75 | Upgrade
|
| Net Income to Common | -75.73 | -212.12 | -288.31 | 137.8 | 228.75 | Upgrade
|
| Net Income Growth | - | - | - | -39.76% | -60.23% | Upgrade
|
| Shares Outstanding (Basic) | 16 | 15 | 15 | 16 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 15 | 15 | 17 | 16 | Upgrade
|
| Shares Change (YoY) | 6.47% | -1.28% | -6.84% | 1.54% | 1.72% | Upgrade
|
| EPS (Basic) | -4.68 | -13.96 | -18.73 | 8.74 | 14.73 | Upgrade
|
| EPS (Diluted) | -4.68 | -13.96 | -18.73 | 8.32 | 14.08 | Upgrade
|
| EPS Growth | - | - | - | -40.91% | -60.71% | Upgrade
|
| Free Cash Flow | - | 287.37 | -795.78 | -278.49 | 73.75 | Upgrade
|
| Free Cash Flow Per Share | - | 18.91 | -51.70 | -16.86 | 4.53 | Upgrade
|
| Gross Margin | 38.46% | 26.36% | 19.39% | 20.89% | 20.71% | Upgrade
|
| Operating Margin | -25.88% | -8.30% | -9.90% | 1.50% | 2.71% | Upgrade
|
| Profit Margin | -41.47% | -8.50% | -6.96% | 2.21% | 3.56% | Upgrade
|
| Free Cash Flow Margin | - | 11.52% | -19.21% | -4.46% | 1.15% | Upgrade
|
| EBITDA | -39.79 | -152.65 | -351.62 | 145.83 | 201.33 | Upgrade
|
| EBITDA Margin | -21.79% | -6.12% | -8.49% | 2.33% | 3.13% | Upgrade
|
| D&A For EBITDA | 7.46 | 54.45 | 58.62 | 51.88 | 27.13 | Upgrade
|
| EBIT | -47.25 | -207.1 | -410.24 | 93.94 | 174.2 | Upgrade
|
| EBIT Margin | -25.88% | -8.30% | -9.90% | 1.50% | 2.71% | Upgrade
|
| Effective Tax Rate | - | - | - | 7.27% | 11.94% | Upgrade
|
Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.